A Long-Term Follow-up Study to Evaluate the Safety and Efficacy of Adeno Associated Virus (AAV) Serotype 8 (AAV8)-Mediated Gene Transfer of Glucose-6-Phosphatase (G6Pase) in Adults with Glycogen Storage Disease Type Ia (GSDIa)
Latest Information Update: 10 Mar 2025
At a glance
- Drugs Pariglasgene-brecaparvovec (Primary)
- Indications Glycogen storage disease type I
- Focus Adverse reactions
- Sponsors Ultragenyx Pharmaceutical
Most Recent Events
- 06 Mar 2025 Status changed from active, no longer recruiting to completed.
- 21 Apr 2023 Planned End Date changed from 1 Dec 2025 to 1 Dec 2026.
- 21 Apr 2023 Planned primary completion date changed from 1 Dec 2025 to 1 Dec 2026.